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Transforming growth factor-b1 antisense oligodeoxynucleo- curately than glomerular injury [1, 2]. Fibrotic structural
tides block interstitial fibrosis in unilateral ureteral obstruction. derangement of the tubulointerstitial compartment oc-
Background. Interstitial expression of transforming growth curs in virtually progressive renal diseases. Interstitialfactor-b1 (TGF-b1) is important in tubulointerstitial fibrosis,
fibrosis is characterized by the accumulation of matrixa common process in most progressive renal diseases. However,
proteins in the renal tubulointerstitial compartment. Theno effective therapy for progressive interstitial fibrosis is
known. Recently, we developed an artificial viral envelope mechanisms underlying the progression of interstitial fi-
(AVE)-type hemagglutinating virus of Japan (HVJ) liposome- brosis are not well understood, but this accumulation of
mediated retrograde ureteral gene transfer method, which al- matrix is accompanied by infiltrating macrophages andlowed us to introduce the genetic material selectively into renal
increased numbers of activated fibroblasts in the intersti-interstitial fibroblasts.
tium [3].Method. We introduced antisense or scrambled oligodeoxy-
nucleotides (ODNs) for TGF-b1 into interstitial fibroblasts in Although several cytokines have fibrogenic potential,
rats with unilateral ureteral obstruction, a model of interstitial transforming growth factor-b (TGF-b) remains the
fibrosis, to block interstitial fibrosis by retrograde ureteral in-
prime fibrogenic cytokine in renal interstitial fibrosis.jection of AVE-type HVJ liposomes.
Active TGF-b evokes a variety of responses relevant toResults. TGF-b1 and type I collagen mRNA increased mark-
edly in the interstitium of untreated obstructed kidneys, and renal fibrosis [4]. TGF-b stimulates synthesis of individ-
those were not affected by scrambled ODN transfection. ual matrix components, including proteoglycans, colla-
Northern analysis and in situ hybridization revealed that the gens, and glycoproteins [5]. TGF-b also inhibits matrix
levels of TGF-b1 and type I collagen mRNA were dramatically
degradation by decreasing synthesis of proteases anddecreased in antisense ODN-transfected obstructed kidneys.
increasing synthesis of protease inhibitors [6]. TGF-bConsequently, the interstitial fibrotic area of the obstructed
kidneys treated with antisense ODN was significantly less than modulates the expression of integrin receptors and alters
that of the obstructed kidneys untreated or treated with scram- their relative abundance on the cell surface in a manner
bled ODN. capable of facilitating adhesion to the matrix [7]. TGF-bConclusion. The introduction of TGF-b1 antisense ODN
is also a chemoattractant for fibroblasts [4] and stimu-into interstitial fibroblasts may be a potential therapeutic ma-
lates fibroblast proliferation [8]. The net effect of TGF-bneuver for interstitial fibrosis.
is to shift the balance of matrix synthesis and degradation
toward accumulation of matrix proteins.
By inhibiting TGF-b using a neutralizing antiserumTubulointerstitial inflammation and fibrosis are com-
mon features in a variety of renal diseases that may [9] or neutralizing proteoglycan decorin [10], Border et
predict renal function and long-term prognosis more ac- al have established a role for TGF-b in the anti–Thy-1
model of glomerulonephritis. We have been investigat-
ing the potential of molecular intervention in antagoniz-
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ficial viral envelope. strategy is direct inhibition of TGF-b1 synthesis by appli-
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the binding of TGF-b to its receptor. Because the patho- incubated with purified HVJ inactivated by ultraviolet
irradiation (110 erg/mm2/sec) for three minutes immedi-genesis of glomerulosclerosis and that of tubulointersti-
tial fibrosis share certain key mechanisms, targeting in- ately before use. The mixture was incubated at 48C for
10 minutes and gently shaken for 60 minutes at 378C.terstitial expression of TGF-b1 should be able to prevent
progression of interstitial fibrosis [4]. Targeting intersti- Free HVJ was removed from the HVJ liposomes by dis-
continuous density gradient centrifugation with sucrose.tial cells has proven to be challenging, and inhibition
studies in animal models of progressive interstitial fibro-
Transfer of antisense ODNs by the AVE-type HVJsis largely remain to be performed, because effective
liposome methodvehicles have not been available to introduce the genetic
material into interstitial fibroblasts. We examined the effect of antisense ODNs for TGF-b1
on tubulointerstitial fibrosis in a rat model of unilateralRecently, we pioneered a new strategy of gene transfer
to the renal interstitial fibroblasts [14]. Fluorescein iso- ureteral obstruction. Male Sprague-Dawley (SD) rats at
the age of six weeks (Japan SLC, Inc., Hamamatsu, Ja-thiocyanate (FITC)-labeled ODNs were introduced into
the kidney of normal rats retrogradely via the ureter by pan) were separated into three groups: (1) TGF-b1 anti-
sense ODN-transfected obstructed rats, (2) scrambledusing an artificial viral envelope (AVE)-type hemagglu-
tinating virus of Japan (HVJ) liposome method. FITC- ODN-transfected obstructed rats, and (3) untreated ob-
structed rats. Specificity of action of the antisense ODNlabeled ODNs were accumulated selectively in the nuclei
of the interstitial fibroblasts diffusely in the transfected used here for TGF-b1 has been confirmed in cultured
smooth muscle cells and also in vivo; glomerular TGF-b1kidney 10 minutes after transfection [14]. Here, we de-
scribe the successful introduction of antisense ODN for expression was suppressed in anti–Thy-1 glomerulo-
nephritic rats treated with antisense ODNs for TGF-b1,TGF-b1 into renal interstitial fibroblasts to inhibit inter-
stitial TGF-b1 expression and thereby prevent interstitial but was not affected when treated with scrambled ODNs
[11]. All procedures were handled in a humane fashionfibrosis.
in accordance with the guidelines of the Animal Commit-
tee of Osaka University (Osaka, Japan). SD rats were
METHODS
anesthetized by an intraperitoneal injection of pentobar-
Synthetic oligodeoxynucleotides bital (50 mg/kg). The left kidney and ureter were surgi-
cally exposed by a midline incision, and a polyethyleneSequences of phosphorothioate ODNs for rat TGF-b1
used in this study were antisense ODN, 59-CGAGGGC (PE) 10 tubing (Beckton-Dickinson, Sparks, MD, USA)
was inserted into the left ureter and advanced in a retro-GGCATGGG-39, and scrambled ODN, 59-GCATGGG
CGAGGGGC-39. Antisense TGF-b1 ODNs were com- grade manner. Immediately after clamping the left renal
vein, 300 mL of AVE-type HVJ liposome suspension,plementary to rat TGF-b1 mRNA at the translation initi-
ation region [11]. These ODNs were purchased from which contained approximately 5 mg of antisense or
scrambled ODN, were slowly infused. After 10 minutesBex (Tokyo, Japan). The ODNs were deprotected on a
column, dried, resuspended in balanced salt solution of incubation, the catheter was removed, and the clamp
was released from the renal vein. Thereafter, ureteral(BSS; 140 mmol/L NaCl, 5.4 mmol/L KCl, and 10 mmol/L
Tris-HCl, pH 7.6), and quantitated using a spectropho- obstruction was induced by ligation. Studies were carried
out either four or seven days after the initiation of ob-tometer.
struction.
Preparation of HVJ liposome
RNA preparation and Northern blot analysisArtificial viral envelope-type HVJ liposomes were
prepared as described previously [15], with minor modi- To examine the effect of antisense ODN on the level of
TGF-b1 and type I collagen mRNA expression, Northernfications [14]. Briefly, egg yolk phosphatidyl choline
(ePC; Sigma Chemical, St. Louis, MO, USA), dioleoyl blot analysis was performed. On day 0, antisense or
scrambled ODNs were each introduced into the left ure-phosphatidyl ethanolamine (DOPE; NOF Corporation,
Tsukuba, Japan), egg yolk sphingomyelin (eSph; Sigma), ter in six rats with unilateral ureteral obstruction. Seven
days later, the kidneys were perfused with cold phos-bovine brain phosphatidyl serine (bPS; Avanti Polar
Lipid, Birmingham, AL, USA), and cholesterol (Sigma) phate-buffered saline (PBS), and the cortex was re-
moved, snap frozen in liquid nitrogen, and kept at 2808Cwere mixed in a molar ratio of 16.7:16.7:16.7:10:50 and
dissolved in chloroform at a concentration of 30 mmol/L. until use. The renal cortex was homogenized with a Poly-
tron homogenizer (Kinematica, Switzerland) in TRIzolThe lipid mixture (500 mL, 15 mmol) was transferred to
a glass tube and dried as a thin lipid film by evaporation. reagent (GIBCO BRL, Gaithersburg, MD, USA). Total
RNA was prepared by an acid guanidinium thiocyanate-Dried lipid was hydrated in 200 mL of BSS containing
50 mg of ODN, mixed vigorously with a vortex agitation, phenol-chloroform extraction procedure according to
the manufacturer’s instructions [16]. For Northern analy-and sonicated to form liposomes. The liposomes were
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sis, 20 mg aliquots of total RNA were separated on 1% col. As a negative control, a DIG-labeled sense RNA
probe was used instead of an antisense probe.agarose-formaldehyde gels, transferred onto nylon mem-
branes (Hybond-N1; Amersham, Boston, MA, USA), and
Immunohistochemical studycross-linked by ultraviolet wave irradiation. Partial clones
Glomerular macrophages were stained with the mono-of rat TGF-b1 cDNA [11], type I collagen cDNA [mouse
clonal antibody ED-1 (Serotec, Oxford, UK). To staina1(I) collagen; a kind gift from Dr. T. Tanaka, Kyoto
smooth muscle a-actin (SMaA), a monoclonal antibodyUniversity, Japan] [17], and rat glyceraldehyde-3-phos-
designated clone 1A4 was used (Sigma). Polyclonal rab-phate dehydrogenase (GAPDH) cDNA [11] were la-
bit anti-mouse type I collagen antiserum was obtainedbeled by a random priming method using [a-32P] dATP
from Chemicon International (Temecula, CA, USA).(3000 Ci/mmol; Amersham). Hybridization was carried
Immunohistochemical staining was performed with par-out at 428C overnight in 50% formamide, 10 3 Den-
affin-embedded sections when anti–ED-1 or anti-SMaAhardt’s solution, 1% sodium dodecyl sulfate (SDS), 5 3
antibody was used as the first antibody and with frozenstandard saline citrate (SSC), 50 mmol/L sodium phos-
sections when antitype I collagen antibody was used asphate, and 200 mg/mL salmon sperm DNA. The blots
the first antibody.were washed three times at 508C in 0.5 3 SSC with
Paraffin-embedded sections from obstructed kidneys0.1% SDS, and the signals were quantitated by laser
obtained four and seven days after disease induction, asdensitometry (Scanningimager; Molecular Dynamics,
well as contralateral kidneys as normal controls, wereSunnyvale, CA, USA).
deparaffinized with xylene and graded ethanol solutions.
Frozen sections from obstructed kidneys obtained afterIn situ hybridization
seven days were fixed in ice-cold acetone for 30 minutes.Since evidence is conflicting as to whether interstitial
The frozen sections then were incubated for five minutescells [18] or tubules [19] are a major source of increased
at room temperature in 0.1% trypsin. The various sec-TGF-b1 in a rat model of obstructive nephropathy,
tions then were incubated in a 99:1 methanol/H2O2 solu-the effects of antisense ODN for TGF-b1 on interstitial
tion for 30 minutes at room temperature to inactivateTGF-b mRNA expression were further evaluated at the
the endogenous peroxidase activity, washed three timeshistologic level using in situ hybridization. Antisense and
in PBS for 10 minutes, preincubated at room tempera-sense RNA probes of rat TGF-b1 [11] and a1(I) (type I
ture in blocking solution for 30 minutes [PBS containingcollagen) [17] cDNA were labeled with digoxigenin
5% goat serum and 1% bovine serum albumin (BSA) for(DIG)-labeled uridine triphosphate (UTP) as described
rabbit antiserum or PBS containing 1% BSA for mouse
[20]. All tissues were fixed in freshly prepared 4% para-
monoclonal antibody], and finally washed in PBS for
formaldehyde and processed and embedded in paraffin 3 minutes three times. The first antibodies (anti–ED-1
utilizing conventional techniques. Paraffin-embedded sec- monoclonal antiserum, 1:100; anti-SMaA mouse mono-
tions from obstructed kidneys obtained seven days after clonal antibody, 5 mg/mL; or anti-mouse type I collagen
disease induction were deparaffinized with chloroform polyclonal antiserum, 1:100) were then applied to the
and graded ethanol solutions and then were incubated sections. Incubation with the first antibody was per-
in 0.2 N HCl for 10 minutes, in proteinase K (5 mg/mL) formed for 16 hours at 48C. After removal of unbound
for 20 minutes, and in 0.25% acetic anhydride/0.1 mol/L first antibody by three serial washes in ice-cold PBS, the
triethanolamine for 10 minutes. Hybridization was per- sections were incubated with the second antibody (a
formed at 538C for 16 hours in a solution containing 50% biotinylated goat anti-rabbit antibody, 1:150, or biotinyl-
formamide, 2 3 SSC, 10% dextran sulfate, 10 mmol/L ated goat anti-mouse monoclonal antibody, 1:150, Vec-
Tris-HCl (pH 7.5), 1 mmol/L ethylenediaminetetraacetic tor ABC kit; Vector Laboratories, Inc., Burlingame, CA,
acid (EDTA), 0.1% sarcosyl, 0.02% SDS, 4 3 Denhardt’s USA) for one hour at room temperature, followed by
solution, 500 ng/mL denatured salmon sperm DNA, 500 three washes in ice-cold PBS. After an avidin-biotinyl-
ng/mL yeast transfer RNA, and DIG-labeled riboprobe ated horseradish peroxidase complex (Vector) incuba-
(2.5 mg/mL). Sections were placed in a high-stringency tion for 40 minutes at room temperature, peroxidase
wash (HSW) buffer (50% formamide, 2 3 SSC) for 30 activity was visualized with a solution containing 0.6
minutes at 608C and then were treated with 20 ng/mL mg/mL of p-dimethyl aminobenzaldehyde and 10 mg/mL
of ribonuclease A (Sigma) at 378C for 10 minutes again of H2O2 in 50 mmol/L Tris-HCl (pH 6.85) using DAB-
placed in HSW buffer for 10 minutes, at 608C, in 2 3 buffer tablets (Merck, Darmstadt, Germany). After
SSC at room temperature for 10 minutes and in 0.2 3 counterstaining with methyl green, the sections were
SSC at room temperature for 10 minutes. Immunologic mounted. Negative control studies were performed using
detection of DIG was performed using a Genius nonradio- nonimmunized normal rabbit serum for rabbit polyclonal
active DNA detection kit (Boehringer Mannheim, Mann- antibody and normal mouse IgG (Santa Cruz Biotech-
nology, Santa Cruz, CA, USA) for mouse monoclonalheim, Germany) according to the manufacturer’s proto-
Fig. 1.
Fig. 3.
Fig. 2. Fig. 4.
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Fig. 1. (A) Northern blot of cortical transforming growth factor-b1 (TGF-b1), type I collagen, and GAPDH mRNA in obstructed kidneys from
rats treated with antisense oligodeoxynucleotides (ODN) for TGF-b1 (lane 1) or scrambled ODN (lane 2) untreated disease control rats (lane 3) or
in contralateral normal kidneys (lane 4). (B) In situ hybridization of TGF-b1 mRNA in obstructed kidneys from untreated disease control rats (D),
unilateral ureteral obstruction model rats treated with scrambled ODN (Sc) or antisense ODN (AS), or in contralateral normal kidneys (N; 3100).
b
Fig. 3. Immunohistochemical staining for infiltrated macrophages (A; 3200) and transformed myofibroblast (B; 3100) in obstructed kidneys from
untreated disease control rats (D), unilateral ureteral obstruction model rats treated with scrambled ODN (Sc) or antisense ODN (AS) or in
contralateral normal kidneys (N).
antibody instead of the first antibodies. No staining was injury leading to tubulointerstitial fibrosis that has been
linked to up-regulation of interstitial TGF-b1 expressionobserved in these negative controls.
[21, 22]. Obstructed rats were divided into three groups
Morphometric analysis of the interstitial fibrosis that received either TGF-b1 antisense ODN (antisense
group), scrambled ODN (scrambled group), or no treat-The area of the fibrotic lesion of cortical interstitium
ment (untreated group). In the present experiments,was determined in sections stained by Masson’s tri-
antisense or scrambled ODN-bearing AVE-type HVJchrome method to stain collagen fibers (in light blue) in
liposomes were slowly instilled immediately after clamp-the tubular basement membrane, glomeruli, and intersti-
ing the left renal vein, followed after 10 minutes bytial space. Under high-power magnification (3400), 10
ureteral catheter removal, unclamping of the vein, andnonoverlapping fields from the cortical region were se-
ureteral ligation. Northern blot analysis demonstratedlected at random and analyzed by an observer unaware
that densitometric values of the TGF-b1 mRNA tran-of the experimental protocol. The fibrotic areas in the
script levels were 14.8 6 4.4-fold increased over thoseinterstitium and tubular basement membrane were high-
in normal control kidneys in the untreated group sevenlighted on digitized images using a computer-aided ma-
days after obstruction. However, treatment with anti-nipulator (microscope; Leitz DM IRB, software, Quan-
sense ODN significantly reduced the levels of TGF-b1timet 5001; Leica, Tokyo, Japan). The fibrotic area
mRNA expression in the renal cortex to 30% of thoserelative to the total area of the field was calculated as a
levels in untreated group (4.4 6 2.3-fold increase overpercentage. Glomeruli and large vessels were not in-
normal control levels, P # 0.01 vs. untreated group; Fig.cluded in the microscopic fields for image analysis. The
1A). In contrast, no significant differences in the level
scores of 10 fields per kidney were averaged, after which of TGF-b1 mRNA were seen between the scrambled
the mean scores from six separate animals per group group (16.3 6 5.3-fold increase) and the untreated group.
were averaged. GAPDH mRNA expression remained unaffected in all
transfected rats. In addition, in situ hybridization con-Statistical analysis
firmed that TGF-b1 mRNA was up-regulated in the in-
All values are expressed as the mean 6 SD. Statistical terstitium and tubules of the untreated group and the
significance (defined as P values of less than 0.01) was scrambled group, mainly in the interstitial area, as pre-
evaluated using the one-way analysis of variance (ANOVA). viously reported [23]. This up-regulation was also sup-
pressed in the antisense group (Fig. 1B). No signal was
detected when serial sections from the same kidney wereRESULTS
hybridized with the sense probe (data not shown).
Effect of antisense TGF-b1 ODN transfer on
TGF-b1 expression Effect of antisense TGF-b1 ODN transfer on type I
collagen expressionWe examined the effect of antisense ODN for TGF-b1
on tubulointerstitial fibrosis in rats with unilateral ure- Given the effective suppression of TGF-b1 mRNA,
we assessed type I collagen expression by Northern blotteral obstruction, a well-characterized model of renal
b
Fig. 2. Interstitial expression of type I collagen mRNA and protein seven days after ureteral obstruction. In situ hybridization of type I collagen
mRNA (A; 3200) and immunohistochemical localization of type I collagen protein (B; 3200) in obstructed kidneys from untreated disease control rats
(D), unilateral ureteral obstruction model rats treated with scrambled ODN (Sc) or antisense ODN (AS) or in contralateral normal kidneys (N).
b
Fig. 4. (A) Masson’s trichrome stained kidneys in obstructed kidneys from untreated disease control rats (D), unilateral ureteral obstruction
model rats treated with scrambled ODN (Sc) or antisense ODN (AS), or in contralateral normal kidneys (N; 3400). (B) Morphometric analysis
of relative interstitial fibrotic area. Data are expressed as mean 6 SD. *P , 0.01 vs. D and Sc by analysis of variance.
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analysis (Fig. 1A), in situ hybridization (Fig. 2A), and ing increasingly evident [25, 26]. Alterations in the phe-
notype and behavior of pre-existing renal fibroblasts mayimmunohistochemistry (Fig. 2B). Renal cortical mRNA
levels of type I collagen were low in contralateral normal be one of the most important events associated with
increased matrix synthesis. As shown in Figure 3B, inter-kidneys. In contrast, type I collagen mRNA levels were
15.8 6 4.8-fold increased in the untreated group seven stitial SMaA expression was markedly increased in the
untreated group and the scrambled group, and this dis-days after obstruction. However, treatment with anti-
sense ODN significantly reduced the levels of type I tended expression was blocked in the antisense group.
The observation that TGF-b1 can transform fibroblastscollagen mRNA expression (6.5 6 2.9-fold increase over
normal control levels, P # 0.01 vs. untreated group; Fig. to myofibroblasts [27] complements our results indicat-
ing that a therapeutic strategy targeting interstitial1A). In contrast, no significant differences were seen
between the scrambled group (18.3 6 5.7-fold increase) TGF-b1 could inhibit phenotypic changes in the intersti-
tium.and untreated group. Transcript levels of GAPDH
mRNA expression remained unaffected in all trans-
Effect on interstitial fibrosisfected rats.
Type I collagen expression, which increases in intersti- Kidneys with ureteral obstruction for seven days
showed a greatly expanded interstitium with marked in-tial fibrotic area, was enhanced in interstitial fibrous
spaces in the untreated group and the scrambled group creases in cellular infiltration (Fig. 4A). Note that the
blue staining of the interstitium in the obstructed kidneyas reported previously [24]. When cortical sections of
kidneys from untreated and scrambled group were hy- indicates the interstitial fibrosis. The obstructed kidneys
from either the untreated or scrambled group exhibitedbridized with the antisense riboprobe for type I collagen,
strong signals were exclusively observed in the interstitial increased tubular dilation, with a marked expansion of
the interstitium. In contrast, obstructed kidneys from thearea (Fig. 2A). A slight signal was detected when cortical
sections from antisense ODN-treated obstructed kidneys antisense group showed a minimal interstitial expansion,
or when the contralateral normal kidney was probed although they exhibited the same extent of tubular dila-
with the antisense riboprobe for type I collagen. No tion. In the untreated group or the scramble group, ob-
signal was detected when serial sections from the same struction for seven days resulted in a significant relative
kidney were hybridized with the sense probe (data not increase in fibrotic area compared with the opposite kid-
shown). neys (Fig. 4B). Obstructed kidneys from the antisense
In addition, immunostaining of type I collagen in the group showed a significantly smaller extent of fibrotic
interstitial area was faint in normal kidneys, but strong area than those from the untreated group or the scram-
in untreated obstructed kidneys and scrambled ODN- bled group.
treated obstructed kidneys. In antisense ODN-treated
obstructed kidneys, immunostaining was weak (Fig. 2B).
DISCUSSIONThus, introduction of antisense ODN markedly sup-
This report provides the first clear demonstration, topressed enhanced expression of type I collagen in ob-
our knowledge, that introduction of antisense ODN forstructed kidneys.
TGF-b1 into interstitial fibroblasts by the AVE-type
Effect on macrophage infiltration and HVJ liposome gene delivery system can suppress inter-
SMaA expression stitial TGF-b1 expression and thereby block consequent
interstitial fibrosis in rats with unilateral ureteral obstruc-Macrophage infiltration of the interstitium and in-
tion. Despite various approaches and techniques, fewcreased numbers of activated fibroblasts (myofibroblasts)
reports of success have emerged concerning in vivo trans-accompany interstitial matrix accumulation. Infiltrated
fection targeting interstitial fibroblasts, which have beeninterstitial macrophages and SMaA, a myofibroblast
highlighted as the source of increased extracellular ma-marker, were stained with monoclonal antibodies desig-
trix synthesis [24]. Recently, Zhu et al have reportednated ED-1 and clone 1A4, respectively. The number of
successful adenoviral vector transfection into the intersti-ED1-positive cells in the interstitium increased in ob-
tial compartment. In that work, expression of the b-structed kidneys compared with the opposite kidney four
galactosidase gene was reported in the interstitial vascu-days after disease induction (Fig. 3A), but no significant
lature including arteries of the outer medulla in bothdifferences were seen in the number of ED1-positive
the outer and inner stripes and in periglomerular andcells between the three treatment groups either on day 4
peritubular capillaries of the cortex [28]. In contrast,(23.9 6 5.9, 23.8 6 6.5, and 25.5 6 6.5 cells per high-
retrograde introduction via the ureter using an AVE-power fields in the untreated group, the scrambled group,
type HVJ liposome method enabled us to introduceand the antisense group, respectively) or on day 7 (39.5 6
ODN selectively into interstitial fibroblasts.9.4, 41.5 6 10.4, and 44.3 6 12.1, respectively).
Phenotypic plasticity of resident fibroblasts is becom- As we previously observed [14], TGF-b1 antisense
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ODN were introduced into neither macrophages nor and that there appeared to be substantially more TGF-b
mRNA in the interstitium of obstructed kidneys of wild-tubular cells, but fibroblasts, suggesting that TGF-b1
antisense ODN could directly affect TGF-b1 expression type mouse as opposed to those of osteopontin-null mu-
tant mouse at day 7 [23]. They suggested that the reduc-in interstitial fibroblasts. Importantly, Northern blot anal-
ysis and in situ hybridization demonstrated that TGF-b1 tion in TGF-b in osteopontin-null mutant mice could
account for the tubulointerstitial fibrosis. In this diseaseantisense ODN transfection into interstitial fibroblasts
significantly reduced interstitial TGF-b1 mRNA expres- model, interstitial TGF-b1 may have less effect on mac-
rophage infiltration than the chemotactic factors releasedsion and prevented interstitial fibrosis in obstructed kid-
neys. Evidence is conflicting as to whether interstitial by tubular cells. In contrast, interstitial SMaA expression
was markedly increased in the untreated group and thecells [18] or tubules [19] are a major source of increased
TGF-b1 in a rat model of obstructive nephropathy. In scrambled group, whereas this extensive expression was
prevented in antisense group. Whether TGF-b1 is di-situ hybridization studies performed to date have high-
lighted interstitial cells as the source [29]. A recent report rectly mediating interstitial SMaA expression or is acting
indirectly by producing and/or activating other factors,showed that there appeared to be substantially more
TGF-b mRNA in the interstitium of obstructed kidneys which might be responsible for the activation of fibro-
blasts, was not determined in this study. In addition,of wild-type mouse as opposed to those of osteopontin-
null mutant mouse at day 7 [23]. Kaneto et al reported antisense ODN blocked the interstitial up-regulation of
type I collagen and interstitial fibrosis. These results sup-the immunoreactivity for TGF-b increased markedly in
the interstitium of human obstructed kidneys, but not in port our hypothesis that interstitial fibroblasts play an
important role in TGF-b1 expression and the consequenttubular cells [30]. Our observations were compatible with
the previous impressions that fibroblasts and myofibro- progression of interstitial fibrosis, and that inhibiting in-
terstitial TGF-b1 expression can directly and/or indi-blasts are the major TGF-b1–producing cells [31, 32].
Yamamoto et al showed that TGF-b–positive interstitial rectly prevent the phenotypic alteration of fibroblast and
thereby block interstitial fibrosis.cells exhibit immunoreactivity for fibroblastic/myofibro-
blastic cells but not for monocytes/macrophages [32]. We This study demonstrated that interstitial expression of
TGF-b1 is a key stimulus for interstitial fibrosis. The devel-demonstrated that TGF-b1 mRNA was up-regulated in
the interstitium and tubules of the untreated group and opment of therapies targeted against interstitial TGF-b
the scrambled group, mainly in the interstitial area, while should be considered. Although a number of issues such
this up-regulation was also suppressed in antisense group. as safety and side effects were not addressed in this study,
Taken together with our observations, both resident re- we should point out that retrograde ureteral catheteriza-
nal tubular cells and interstitial cells may be responsible tion is a common clinical procedure. Therefore, this new
for TGF-b production; however, interstitial fibroblast molecular strategy of gene transfer to interstitial cells
cells may be the major source of TGF-b in the formation could represent a powerful investigative and potentially
of interstitial fibrosis. As we demonstrated that the intro- therapeutic strategy in interstitial renal disease.
duction of antisense TGF-b1 ODN into the interstitial
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